RxDoctor Payments DataLook up a doctor →

Anna Szafran-Swietlik, MD

Endocrinology, Diabetes & Metabolism · Hudson, FLNPI 1780815340

Payments from drug & device makers

$339,567in general payments, 2019–2025

Across 763 payments — averaging $445.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$324K
  • Novo Nordisk$2K
  • Medtronic$2K
  • Amgen$1K
  • Corcept Therapeutics$1K
  • Lilly USA, LLC$1K
  • plus $7K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie32$323,862
Novo Nordisk144$2,455
Medtronic(2 entities)30$2,247
Amgen(2 entities)84$1,422
Corcept Therapeutics56$1,092
Lilly USA, LLC64$1,076
Bayer45$980
Xeris Pharmaceuticals, Inc.34$572
Radius Health, Inc.18$521
Boehringer Ingelheim24$520
Sanofi-aventis U.S. LLC24$500
Recordati_rare_diseases_inc.18$461
AstraZeneca21$375
Dexcom, Inc.11$297
Amneal Pharmaceuticals LLC17$289
Insulet Corporation7$277
Mannkind Corporation10$209
Tandem Diabetes Care, Inc.10$204
Merck13$177
BETA Bionics, Inc.9$163
IBSA Pharma Inc.8$161
Amryt Pharma Holdings Ltd3$159
Lexicon Pharmaceuticals, Inc.7$155
Novartis7$123
Amarin Pharma, Inc.6$117
Abbott6$108
Pfizer7$106
Zealand Pharma US, Inc.4$84
Lifescan, Inc.5$84
Kyowa Kirin, Inc.3$83
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$76
Nevro Corp.4$74
Ascendis Pharma Endocrinology Inc3$57
Valeritas, Inc.4$57
Rhythm Pharmaceuticals, Inc.2$56
Sequel Med Tech, LLC2$55
Companion Medical, Inc.3$53
Esperion Therapeutics, Inc.2$30
Neurocrine Biosciences, Inc.1$29
EUSA Pharma (US) LLC1$25
Renalytix AI, Inc.1$23
Cequr Corporation1$23
Avvisto Therapeutics, LLC1$20
GSK1$20
Ipsen Biopharmaceuticals, Inc1$20
Astellas Pharma US Inc1$18
Vivus LLC1$14
Antares Pharma, Inc.1$14
Shire North American Group Inc1$12
Johnson & Johnson1$12

How this compares

$339,567 in reported general payments places this provider in the 90th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Medicare billing

Part B allowed, 2024
$254,457
Medicare patients
441
Services billed
6,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Hudson

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →